Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Amgen (AMGN) Stock Valuation Looks Split Between Analyst Targets And DCF Upside
Morgan Stanley Raises Amgen (AMGN) Price Target Following a Strong Start for Uplizna
Wall Street Zen Upgrades Amgen (NASDAQ:AMGN) to Buy
Amgen Faces Dual Turning Point With IMDYLLTRA Gain And Tavneos Risk
Victory Capital Management Inc. Grows Holdings in Amgen Inc. $AMGN
Van ECK Associates Corp Lowers Position in Amgen Inc. $AMGN
Korea Investment CORP Trims Stake in Amgen Inc. $AMGN
First National Bank of Omaha Boosts Position in Amgen Inc. $AMGN
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Position in Amgen Inc. $AMGN - Daily Political
Rhenman & Partners Asset Management AB Acquires Shares of 36,000 Amgen Inc. $AMGN - Daily Political
Amgen (AMGN) Stock After Horizon Deal And Strong Multi‑Year Gains Is Price Still Reasonable
Amgen Defends Tavneos Amid FDA Withdrawal Proposal
WealthPLAN Partners LLC Decreases Stock Position in Amgen Inc. $AMGN - Markets Daily
Swiss National Bank Sells 74,660 Shares of Amgen Inc. $AMGN
Amgen's $500 Million Tavneos Faces FDA Withdrawal Fight
Nuveen LLC Has $643.46 Million Stock Position in Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Acquired by Sumitomo Mitsui Financial Group Inc.
Nuveen LLC Sells 86,287 Shares of Amgen Inc. $AMGN
Aviva PLC Purchases 23,465 Shares of Amgen Inc. $AMGN
Xponance LLC Raises Position in Amgen Inc. $AMGN - Daily Political
Amgen Inc. $AMGN Position Reduced by Vaughan David Investments LLC IL - Daily Political
Amgen Retains Research Firm to Validate Tavneos Drug Efficacy Amid FDA Approval Concerns, ETPharma
Amgen (AMGN) Faces FDA Scrutiny Over Tavneos Amid Safety Concern
Amgen Reevaluates Tavneos Data as Drug Faces FDA Scrutiny (1)
A Look at Amgen Inc (AMGN) After 4.8% Gain -- GF Value $353.35 vs Price $354.06
Amgen's Repatha Diabetes Data Reframes Cardiometabolic Upside For Investors
Is Amgen Inc. (AMGN) A Good Stock To Buy Now?
Metis Global Partners LLC Sells 2,052 Shares of Amgen Inc. $AMGN - Zolmax
Metis Global Partners LLC Has $7.75 Million Stake in Amgen Inc. $AMGN - Markets Daily
7 Best Longevity Stocks to Buy Now
Inceptionr LLC Buys 1,714 Shares of Amgen Inc. $AMGN - Stock Observer
J.Safra Asset Management Corp Takes Position in Amgen Inc. $AMGN
ING Groep NV Buys New Shares in Amgen Inc. $AMGN
Gilpin Wealth Management LLC Takes Position in Amgen Inc. $AMGN
Capital Wealth Planning LLC Raises Position in Amgen Inc. $AMGN
Townsquare Capital LLC Sells 3,602 Shares of Amgen Inc. $AMGN - Stock Observer
Ethyreal Bio manifests with $101M in pack of biotechs gunning for Amgen's Tepezza | Fierce Biotech
Amgen (AMGN) - Analysts' Recent Ratings Changes - Daily Political
Deutsche Bank AG Cuts Position in Amgen Inc. $AMGN - Markets Daily
TIAA Trust National Association Lowers Stock Holdings in Amgen Inc. $AMGN - Stock Observer
Amgen Obesity Head: 90% of the obesity market is untreated
Amgen Eyes 2026 'Springboard' as Growth Drugs Offset Patent Pressure
Apollo Therapeutics Appoints Timothy P. Walbert as Chairman of the Board
Amgen Inc. $AMGN Shares Purchased by LPL Financial LLC
Goldman Sachs Trims Amgen (AMGN) Valuation but Sticks with Buy Rating
Amgen Inc. $AMGN Shares Bought by Erste Asset Management GmbH
Hilton Head Capital Partners LLC Purchases Shares of 3,798 Amgen Inc. $AMGN - Daily Political
Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants
Amgen (AMGN) Unveils Promising Data on Diabetes at ADA Conference
What to know about MariTide, Amgen's experimental GLP-1 drug
XML Financial LLC Lowers Position in Amgen Inc. $AMGN - Markets Daily
PBU The Pension Fund of Early Childhood & Youth Educators Takes $7.08 Million Position in Amgen Inc. $AMGN - Markets Daily
Should Amgen's (AMGN) IMDYLLTRA Win and Rare-Disease Data Shift Its High-Need Portfolio Strategy?
Amgen Inc. $AMGN Shares Sold by XML Financial LLC - Stock Observer
Capital World Investors Boosts Holdings in Amgen Inc. $AMGN
Amgen Inc. $AMGN Stake Lowered by Capital Research Global Investors - Daily Political
Amgen Inc. $AMGN Shares Sold by Capital International Investors - Stock Observer
Capital International Ltd. CA Trims Stake in Amgen Inc. $AMGN - Daily Political
The Smartest Dividend ETF to Buy With $1,000 Right Now -- and It's Up 19% in 2026 - AOL
What to know about berobenatide, Pfizer's experimental obesity drug
SpaceX IPO Could Create 'The Biggest Short Squeeze' of All Time on Index Funds. Here's How That Happens.
Vestcor Inc Decreases Holdings in Amgen Inc. $AMGN - Markets Daily
Vestcor Inc Sells 10,133 Shares of Amgen Inc. $AMGN
Amgen Inc. $AMGN Position Boosted by Vise Technologies Inc.
J.W. Cole Advisors Inc. Sells 6,407 Shares of Amgen Inc. $AMGN
Vise Technologies Inc. Grows Stock Position in Amgen Inc. $AMGN - Stock Observer
Amgen (NASDAQ:AMGN) Cut to Hold at Wall Street Zen
MCF Advisors LLC Increases Position in Amgen Inc. $AMGN - Daily Political
Amgen Inc. (AMGN) Announces EC's Grant of Marketing Authorization for IMDYLLTRA®
Is There Still Opportunity In Amgen (AMGN) After Its 24% One-Year Share Price Gain
Intellectus Partners LLC Sells 2,286 Shares of Amgen Inc. $AMGN - Zolmax
Daiwa Securities Group Inc. Boosts Holdings in Amgen Inc. $AMGN - Zolmax
Amgen Inc. $AMGN Shares Acquired by Daiwa Securities Group Inc.
Cibc World Market Inc. Acquires 7,112 Shares of Amgen Inc. $AMGN
TD Asset Management Inc Sells 18,473 Shares of Amgen Inc. $AMGN - Stock Observer
Amgen Touts MariTide, AI Gains and 2026 Growth Plans at Jefferies Conference
Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial
Amgen Inc at Jefferies Global Healthcare Conference in New York Transcript
Archvest Wealth Advisors Inc. Buys Shares of 3,801 Amgen Inc. $AMGN
28,909 Shares in Amgen Inc. $AMGN Acquired by Avalon Capital Management
Marble Wealth LLC Acquires New Holdings in Amgen Inc. $AMGN - Stock Observer
Assessing Amgen (AMGN) Valuation After Imdelltra Approval And Concerns Over Tavneos And Prolia
Archvest Wealth Advisors Inc. Purchases New Shares in Amgen Inc. $AMGN - Daily Political
Amgen Inc. $AMGN Position Reduced by Bank of New York Mellon Corp - Zolmax
AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026 | Morningstar
CIBC Asset Management Inc Buys 44,110 Shares of Amgen Inc. $AMGN
Bank of New York Mellon Corp Trims Position in Amgen Inc. $AMGN
EU Approval Of IMDYLLTRA Puts Amgen's Lung Cancer Ambitions In Focus
Amgen Inc. $AMGN Shares Sold by Bridges Investment Management Inc. - Daily Political
